Torigen Pharmaceuticals
company
About
Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $13M
- Industries
- Biotechnology,Health Care,Veterinary
- Founded date
- Jan 1, 2013
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Torigen Pharmaceuticals focuses on providing cancer care solutions for animals. They strive to bring novel approaches to the market to tackle companion animal cancers, building on years of existing scientific research and pushing the boundaries of innovation.The company was founded in 2013 by Ashley Kalinauskas and Mark Suckow and is based in Farmington, Connecticut, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$13M
Torigen Pharmaceuticals has raised a total of
$13M
in funding over 2 rounds. Their latest funding was raised on
Nov 16, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 16, 2022 | Series A | $13M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Torigen Pharmaceuticals is funded by 2 investors.
Advantage Capital
and Gaingels
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Advantage Capital
|
— | Series A |
Gaingels
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
